<DOC>
	<DOCNO>NCT00108914</DOCNO>
	<brief_summary>The purpose study determine investigational drug effective safe child perennial allergic rhinitis .</brief_summary>
	<brief_title>Perennial Allergic Rhinitis Study In Pediatric Subjects</brief_title>
	<detailed_description>A Randomized , Double-Blind , Placebo-Controlled , Parallel-Group , Multicenter Study Evaluate Safety Efficacy Once-Daily , Intranasal Administration GW685698X Aqueous Nasal Spray 50mcg 100mcg 12 Weeks Pediatric Subjects Ages 2 &lt; 12 Years Perennial Allergic Rhinitis ( PAR )</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>Inclusion criterion : Diagnosis perennial allergic rhinitis . Exclusion criterion : Have significant concomitant medical condition . Use corticosteroid allergy medication study . Have abnormal ECG . Have laboratory abnormality . Have abnormal eye exam .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Perennial allergic rhinitis</keyword>
	<keyword>pediatric</keyword>
</DOC>